Positron Acquires IS2 Medical Systems

Positron Corporation, a Houston, TX-based developer and manufacturer of positron emission tomography (PET) medical devices and a leader in cardiac PET, announced today that it has completed the acquisition of IS2 Medical Systems, Inc. (IS2) a leading developer and manufacturer of nuclear imaging devices based in Ottawa, Ontario, Canada.
    IS2’s signature product is its PulseCDC compact digital cardiac camera which provides the best quality images at the lowest price in the industry.
    Positron’s investment in IS2 is the first transaction from proceeds of its recent financing that is dedicated for the expansion of its cardiac camera and clinic businesses. The acquisition adds immediate value to Positron as a technological leader in nuclear medicine devices. Positron will benefit from IS2’s top tier technical resources, marketing expertise and credibility in the nuclear medicine marketplace.
    “This transaction will be a catalyst for continued sales growth while also allowing synergies from sister companies to contribute toward the develop of new technologies in PET, cardiac and general purpose imaging as well as the development of specialized technologies including breast, brain, and prostate imaging,” commented Steve Horvath, president of IS2.